Yadegarynia D, Keyvanfar A, Keyvani H, Tehrani S, et al. Corrigendum to "Immunogenicity and safety of a quadrivalent recombinant influenza vaccine manufactured in Iran (FluGuard) in volunteers aged 18-60 years: A double-blind, non-inferiority, randomized controlled trial" [Vaccine 42(9) (2024) 2254-2259]. Vaccine 2026;88:128881.
PMID: 42365746